DuPont/Evogene GM soybean deal
DuPont and Israeli plant genomics company Evogene (Rehovot) have entered into a multi-year collaboration to develop genetically modified disease-resistant soybeans. The companies will jointly develop a genomic database specifically tailored to soybean rust resistance. Evogene will use its “Athlete” computational genomic technology to identify novel genes and DuPont seed subsidiary Pioneer Hi-Bred International will evaluate the genes in GM soybean lines. Evogene will receive milestone payments and royalties on the sales of any resulting products.